Literature DB >> 6257756

Correlation of herpes simplex virus antibody titers and specific lymphocyte stimulation in adult blood donors.

H Moser, F Behrens, R Ziegelmaier, J Hilfenhaus, R Mauler.   

Abstract

Antibody titers to herpes simplex virus type 1 in sera from healthy adult donors were assayed by complement fixation, microneutralization, and an enzyme immunoassay (ELISA). This last test proved to be the most sensitive method for antibody detection. It was estimated that ELISA antibody titers were up to 40-fold higher than neutralizing antibody titers and up to 100-fold higher than complement fixation antibody titers. Due to the higher sensitivity of ELISA, only 3 of 36 blood donors tested in this assay were shown to be seronegative, whereas 6 additional persons of the same group were termed seronegative by the microneutralization assay. Furthermore, four of the latter also did not respond in the complement fixation test. In vitro stimulation of peripheral lymphocytes by using a partially purified herpes simplex virus type 1 particle antigen was achieved for all seropositive blood donors. Only those three donors who were ELISA negative reacted negatively in this stimulation assay. From these results it may be concluded that ELISA is an appropriate method not only for rapid and sensitive antibody determination but also for selecting herpes simplex virus-negative patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6257756      PMCID: PMC273716          DOI: 10.1128/jcm.13.1.36-41.1981

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Cellular immunity and circulating antibody to herpes simplex virus in subjects with recurrent herpex simplex lesions and controls as measured by the mixed leukocyte migration inhibition test and complement fixation.

Authors:  R W Gange; A de Bats; J R Park; C M Bradstreet; E L Rhodes
Journal:  Br J Dermatol       Date:  1975-11       Impact factor: 9.302

2.  Herpes simplex virus microneutralization: a simplification of the test.

Authors:  H Stalder; M N Oxman; K L Herrmann
Journal:  J Infect Dis       Date:  1975-04       Impact factor: 5.226

3.  Depressed specific cell-mediated immunity to Herpes simplex virus type 1 in patients with recurrent herpes labialis.

Authors:  Y H Thong; M M Vincent; S A Hensen; D A Fuccillo; M Rola-Pleszczynski; J A Bellanti
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

4.  A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans.

Authors:  R G Douglas; R B Couch
Journal:  J Immunol       Date:  1970-02       Impact factor: 5.422

5.  Immunological relationship between herpes simplex and varicella-zoster viruses demonstrated by complement-fixation, neutralization and fluorescent antibody tests.

Authors:  N J Schmidt; E H Lennette; R L Magoffin
Journal:  J Gen Virol       Date:  1969-04       Impact factor: 3.891

6.  Concentration and purification of herpesviruses (simplex, cytomegalo, and EB) in a zonal ultracentrifuge.

Authors:  R M McCombs
Journal:  Appl Microbiol       Date:  1969-04

7.  Investigation and standardization of the conditions for micro-lymphocyte cultures.

Authors:  M G Du Bois; D R Huismans; P T Schellekens; V P Eijsvoogel
Journal:  Tissue Antigens       Date:  1973

8.  Effect of adenine arabinoside on severe Herpesvirus hominis infections in man.

Authors:  L T Ch'ien; N J Cannon; L J Charamella; W E Dismukes; R J Whitley; R A Buchanan; C A Alford
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

9.  Enzyme-immunoassays for antibodies in measles, cytomegalovirus infections and after rubella vaccination.

Authors:  A Voller; D E Bidwell
Journal:  Br J Exp Pathol       Date:  1976-04

10.  Relative concentrations in human sera of antibodies to cross-reacting and specific antigens of Herpes simplex virus types 1 and 2.

Authors:  H McClung; P Seth; W E Rawls
Journal:  Am J Epidemiol       Date:  1976-08       Impact factor: 4.897

View more
  2 in total

1.  Escherichia coli-derived envelope protein gD but not gC antigens of herpes simplex virus protect mice against a lethal challenge with HSV-1 and HSV-2.

Authors:  M Bröker; K J Abel; R Köhler; J Hilfenhaus; E Amann
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

2.  Protectivity of herpes simplex virus antigens: studies in mice on the adjuvant effect of PICLC and on the dependence of protection on T cell competence.

Authors:  J Hilfenhaus; H Christ; R Köhler; H Moser; H Kirchner; H B Levy
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.